BioSpace News Archive

FDA

Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine Spikevax

Moderna, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for SPIKEVAX (COVID-19 Vaccine, mRNA) to prevent COVID-19 in individuals 18 years of age and older.

January 31, 2022
·
6 min read
Deals

Zymeworks Announces Closing of Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

Zymeworks Inc. today announced the closing of its previously announced underwritten public offering of 11,035,000 common shares.

January 31, 2022
·
2 min read
Biotech Bay

Minerva Surgical to Present at the 11th Annual SVB Leerink Global Healthcare Conference

Minerva Surgical, Inc., a woman’s health company focused on the treatment of Abnormal Uterine Bleeding, announced that its management will present at the 11th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 16, 2022 at 3:40 p.m. Eastern Time.

January 31, 2022
·
1 min read
Business

Ensysce Biosciences Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communication Program

Ensysce Biosciences, Inc. announced today the Company has engaged international investor relations specialists MZ Group (“MZ”) to lead a comprehensive strategic investor relations and financial communications program.

January 31, 2022
·
7 min read
BioCapital

Gain Therapeutics Announces Additional Details on its February 4th Virtual R&D Day

Gain Therapeutics, Inc. today announced additional details on its R&D Day being held virtually on Friday, February 4, 2022 from 10:00 am – 12:00 pm Eastern Time.

January 31, 2022
·
7 min read
Business

Augmedix Announces Preliminary Fourth Quarter 2021 Financial Results

Augmedix, Inc. today announced preliminary unaudited financial and operational results for the three months ended December 31, 2021.

January 31, 2022
·
5 min read
Business

NuVasive Appoints Andrew C. Morton as Chief Human Resources Officer

NuVasive, Inc. today announced the appointment of Andrew (Drew) C. Morton as senior vice president and chief human resources officer (CHRO) effective February 7, 2022 .

January 31, 2022
·
3 min read
Business

Quotient Limited to Report Third Quarter Fiscal Year 2022 Financial Results and Host Conference Call

Quotient Limited today announced that financial results for its fiscal third quarter ended December 31, 2021 will be released before market open on Tuesday, February 8, 2022.

January 31, 2022
·
1 min read
Business

Checkmate Pharmaceuticals Welcomes Industry Leader Jon Wigginton, M.D. to its Board of Directors

Checkmate Pharmaceuticals, Inc. today announced the addition of Jon Wigginton, M.D. to its Board of Directors (“Board”).

January 31, 2022
·
6 min read
Drug Development

Denovo Biopharma LLC Announces FDA Approval of IND to Initiate First Biomarker-Guided Global CNS Clinical Trial for Treatment-Resistant Depression (TRD)

Denovo Biopharma LLC today announced that the FDA has authorized the company’s investigational new drug (IND) application of DB104.

January 31, 2022
·
2 min read